发明名称 Cytotoxicity mediation of cells evidencing surface expression of CD44
摘要 <p>Disclosed is the use of an isolated monoclonal antibody, or antigen binding fragment thereof, produced by the hybridoma cell line deposited with ATCC as accession number PTA-4621 for the manufacture of a medicament for the treatment of a breast tumor that is negative for Her2 expression.</p>
申请公布号 NZ550045(A) 申请公布日期 2009.10.30
申请号 NZ20050550045 申请日期 2005.03.23
申请人 F. HOFFMANN-LA ROCHE AG 发明人 YOUNG, DAVID S F;HAHN, SUSAN E;FINDLAY, HELEN P
分类号 A61K39/395;A61K47/48;A61K49/00;A61P35/00;C07K16/00;C07K16/28;C07K16/30;G01N33/50;G01N33/566;G01N33/567;G01N33/569;G01N33/574 主分类号 A61K39/395
代理机构 代理人
主权项
地址